| Literature DB >> 35328985 |
Clifton J Holmes1,2, Susan B Racette1,2, Leslie Symonds3, Ana Maria Arbeláez3, Chao Cao1, Andrea Granados4.
Abstract
The aims of this study were to (1) determine the feasibility of a home-based resistance exercise training (RET) program in patients with cystic fibrosis and impaired glucose tolerance using virtual personal training and (2) observe the effects completion of the RET program had on glucose metabolism, pulmonary function, body composition, and physical fitness. The feasibility of the program was defined as 80% compliance. Ten participants (15.80 ± 2.20 yr, 25.1 ± 7.4 kg/m2) began a home-based resistance training program consisting of 36 sessions supervised via online videoconferencing. Compliance scores of 78.9% (all participants) and 81.8% (without one outlier) were observed. A significant increase was observed in 2-h C-peptide levels (2.1 ng/mL; p = 0.04), with a moderate decrease in fasting glucose (-5.2 mg/dL; p = 0.11) and a moderate increase in 2-h insulin (35.0 U/mL; p = 0.10). A small decrease in the fat percentage (-1.3%; p = 0.03) was observed in addition to increases in fat-free mass (1.5 kg; p = 0.01) and the fat-free mass index (0.4; p = 0.01). Small, yet statistically significant increases were observed in V̇O2peak (0.1 L/min p = 0.01), V̇CO2peak (0.1 L/min; p = 0.01), and ventilation (5.3 L/min; p = 0.04). Telehealth-based RET is feasible in adolescents with CF and impaired glucose tolerance and elicits small yet favorable changes in insulin secretion, body composition, and exercise capacity.Entities:
Keywords: COVID-19; body composition; cystic-fibrosis-related diabetes; fitness; telemedicine
Mesh:
Year: 2022 PMID: 35328985 PMCID: PMC8950531 DOI: 10.3390/ijerph19063297
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Descriptive data.
| Age (yr) | 15.80 ± 2.20 |
| Height (cm) | 163.97 ± 9.31 |
| Height Z-score | −0.21 ± 0.68 |
| Weight (kg) | 60.05 ± 15.12 |
| Weight Z-score | −0.04 ± 1.58 |
| Body Mass Index (kg/m2) | 22.55 ± 6.52 |
| Body Mass index Z-score | −0.09 ± 1.70 |
| Fasting Glucose (mg/dL) | 100.80 ± 11.30 |
| 2-h Glucose (mg/dL) | 156.22 ± 45.41 |
| Forced Expiratory Volume (FEV1%) | 109.13 ± 17.64 |
| Forced Vital Capacity (FVC1%) | 109.25 ± 14.34 |
Resistance exercise session compliance.
| Participant | Completed Sessions | Missed Sessions | Completed Percentage |
|---|---|---|---|
| 001 | 31 | 5 | 86.1 |
| 002 | 30 | 6 | 83.3 |
| 003 | 30 | 6 | 83.3 |
| 004 | 28 | 8 | 77.8 |
| 005 | 29 | 7 | 80.6 |
| 006 | 32 | 4 | 88.9 |
| 007 | 31 | 5 | 86.1 |
| 008 | 19 | 17 | 52.8 |
| 009 | 29 | 7 | 80.6 |
| 010 | 25 | 11 | 69.4 |
| M ± SD | 28.4 ± 3.8 | 7.6 ± 3.8 | 78.9 ± 10.7 |
M = mean, SD = standard deviation.
Figure 1Average completed volume-load progression; n = number of participants who completed exercise sessions for that week.
Metabolic marker pre-post changes.
|
| Pre-Intervention | Post-Intervention | Mean Difference | ES | ||
|---|---|---|---|---|---|---|
| Fasting Glucose (mg/dL) | 10 | 100.8 ± 11.3 | 95.6 ± 5.3 | −5.2 | 0.6 | 0.11 |
| 2-h Glucose (mg/dL) | 9 | 156.2 ± 45.4 | 158.9 ± 40.4 | 2.7 | 0.1 | 0.84 |
| Fasting Insulin (U/mL) | 10 | 9.7 ± 5.5 | 11.3 ± 8.7 | 1.6 | 0.2 | 0.36 |
| 2-h Insulin (U/mL) | 9 | 85.0 ± 42.6 | 120.0 ± 91.3 | 35.0 | 0.5 | 0.10 |
| Fasting C-peptide (ng/mL) | 10 | 2.0 ± 0.7 | 2.1 ± 1.2 | 0.1 | 0.2 | 0.54 |
| 2-h C-peptide (ng/mL) | 9 | 9.6 ± 3.0 | 11.7 ± 4.9 | 2.1 * | 0.5 | 0.04 |
| Matsuda Index | 9 | 4.1 ± 2.5 | 4.0 ± 3.7 | −0.1 | 0.03 | 0.93 |
| HOMA-IR | 9 | 2.4 ± 1.3 | 2.8 ± 2.1 | 0.4 | 0.3 | 0.35 |
| OGIS | 8 | 363.6 ± 42.0 | 362.4 ± 75.9 | −1.2 | 0.02 | 0.96 |
| Insulin/Glucose-iAUC | 9 | 0.6 ± 0.5 | 0.6 ± 0.4 | −0.1 | 0.2 | 0.59 |
HOMA-IR = homeostatic model assessment of insulin resistance; OGIS = oral glucose insulin sensitivity; iAUC = incremental area under the curve; * significant alpha level at p < 0.05.
Body composition pre-post changes.
|
| Pre-Intervention | Post-Intervention | Mean Difference | ES | ||
|---|---|---|---|---|---|---|
| %Fat | 10 | 29.7 ± 14.7 | 28.4 ± 15.3 | −1.3 * | 0.1 | 0.03 |
| FM | 10 | 19.3 ± 14.1 | 19.0 ± 15.0 | −0.3 | 0.02 | 0.60 |
| FFM | 10 | 40.8 ± 7.2 | 42.3 ± 7.2 | 1.5 * | 0.2 | 0.01 |
| LBM | 10 | 39.6 ± 7.1 | 40.6 ± 7.0 | 1.0 | 0.1 | 0.09 |
| FMI | 10 | 6.8 ± 5.5 | 6.0 ± 6.2 | −0.8 | 0.1 | 0.23 |
| FFMI | 10 | 14.1 ± 1.8 | 14.5 ± 1.9 | 0.4 * | 0.2 | 0.01 |
| LBMI | 10 | 13.4 ± 1.8 | 12.5 ± 5.0 | −0.9 | 0.3 | 0.52 |
| FMI-Z-score | 10 | −0.7 ± 1.6 | −0.9 ± 1.9 | −0.2 | 0.1 | 0.13 |
| LBMI-Z-score | 10 | −0.8 ± 1.2 | −0.9 ± 1.2 | −0.1 | 0.04 | 0.88 |
%Fat = percent body fat; FFM = fat-free mass; FFMI = fat-free mass index; FM = fat mass; FMI = fat mass index; LBM = lean body mass; LBMI = lean body mass index; * significant alpha level at p < 0.05.
Isometric and isokinetic knee extension test metric pre-post changes (N = 10).
| Isometric | Pre-Intervention | Post-Intervention | Mean Difference | ES | |
|---|---|---|---|---|---|
| Peak Torque (N·m) | 117.7 ± 37.8 | 124.8 ± 32.1 | 7.1 ± 13.3 | 0.2 | 0.13 |
| Peak Torque (N·m/kg) | 2.0 ± 0.7 | 2.1 ± 0.7 | 0.1 ± 0.2 | 0.1 | 0.27 |
| Time to Peak Torque (s) | 3.0 ± 1.0 | 2.8 ± 1.0 | −0.3 ± 0.9 | 0.3 | 0.40 |
|
| |||||
| Peak Torque (N·m) | 9.9 ± 35.1 | 95.3 ± 41.9 | 5.4 ± 24.0 | 0.1 | 0.50 |
| Peak Torque (N·m/kg) | 1.6 ± 0.6 | 1.6 ± 0.8 | 0.1 ± 0.5 | 0.1 | 0.64 |
| Work Done (J) | 85.7 ± 42.5 | 98.4 ± 41.7 | 12.7 ± 23.1 | 0.3 | 0.12 |
| Average Power (W) | 73.4 ± 38.6 | 89.5 ± 39.8 | 16.2 ± 17.7 * | 0.4 | 0.02 |
| Time to Peak Torque (s) | 0.4 ± 0.2 | 0.4 ± 0.2 | 0.01 ± 0.2 | 0.2 | 0.91 |
|
| |||||
| Peak Torque (N·m) | 70.4 ± 39.9 | 71.8 ± 32.9 | 1.3 ± 25.0 | 0.04 | 0.87 |
| Peak Torque (N·m/kg) | 1.2 ± 0.7 | 1.2 ± 0.6 | −0.01 ± 0.5 | 0.02 | 0.94 |
| Work Done (J) | 67.1 ± 46.2 | 76.2 ± 39.1 | 9.9 ± 24.3 | 0.2 | 0.23 |
| Average Power (W) | 98.0 ± 74.6 | 113.6 ± 63.6 | 21.0 ± 47.0 | 0.2 | 0.19 |
| Time to Peak Torque (s) | 0.3 ± 0.1 | 0.3 ± 0.1 | −0.04 ± 0.2 | 0.00 | 0.54 |
|
| |||||
| Peak Torque (N·m) | 62.1 ± 38.9 | 63.4 ± 29.5 | 1.6 ± 17.5 | 0.04 | 0.78 |
| Peak Torque (N·m/kg) | 1.1 ± 0.70 | 1.1 ± 0.6 | −0.02 ± 0.3 | 0.03 | 0.88 |
| Work Done (J) | 52.0 ± 38.6 | 61.9 ± 35.7 | 6.9 ± 15.0 | 0.3 | 0.18 |
| Average Power (W) | 103.2 ± 86.2 | 124.1 ± 75.6 | 18.2 ± 43.7 | 0.4 | 0.22 |
| Time to Peak Torque (s) | 0.3 ± 0.2 | 0.2 ± 0.1 | −0.03 ± 0.2 | 0.3 | 0.56 |
|
| |||||
| Peak Torque (N·m) | 58.9 ± 31.1 | 60.5 ± 24.6 | 1.6 ± 17.5 | 0.1 | 0.78 |
| Peak Torque (N·m/kg) | 1.0 ± 0.6 | 1.0 ± 0.4 | −0.02 ± 0.3 | 0.02 | 0.88 |
| Work Done (J) | 46.0 ± 33.0 | 52.9 ± 27.4 | 6.9 ± 15.0 | 0.2 | 0.18 |
| Average Power (W) | 106.0 ± 100.0 | 124.2 ± 74.6 | 18.2 ± 43.7 | 0.2 | 0.22 |
| Time to Peak Torque (s) | 0.3 ± 0.2 | 0.3 ± 0.1 | −0.03 ± 0.2 | 0.2 | 0.56 |
* significant alpha level at p < 0.05.
Cycle ergometer V̇O2peak test metric pre-post changes.
|
| Pre-Intervention | Post-Intervention | Mean Difference | ES | ||
|---|---|---|---|---|---|---|
| V̇O2peak (L/min) | 10 | 1.7 ± 0.5 | 1.9 ± 0.6 | 0.1 ± 0.1 * | 0.2 | 0.01 |
| V̇O2peak (mL/kg/min) | 10 | 30.0 ± 10.0 | 31.7 ± 11.2 | 1.7 ± 3.1 | 0.2 | 0.11 |
| V̇CO2peak (L/min) | 10 | 2.1 ± 0.7 | 2.2 ± 0.7 | 0.1 ± 0.1 * | 0.2 | 0.01 |
| V̇CO2peak (mL/kg/min) | 10 | 35.9 ± 12.8 | 37.1 ± 13.6 | 1.2 ± 2.0 | 0.1 | 0.11 |
| RER | 10 | 1.2 ± 0.1 | 1.2 ± 0.1 | −0.03 ± 0.1 | 0.3 | 0.29 |
| V̇E (L/min) | 10 | 51.8 ± 11.3 | 57.1 ± 16.8 | 5.3 ± 6.8 * | 0.4 | 0.04 |
| MWR (W) | 10 | 137.0 ± 49.0 | 135.0 ± 47.9 | −2.0 ± 20.4 | 0.04 | 0.76 |
| MWR (W/kg) | 10 | 2.4 ± 0.9 | 2.3 ± 0.9 | −0.1 ± 0.4 | 0.1 | 0.59 |
| HRmax (bpm) | 10 | 179.5 ± 12.8 | 180.5 ± 16.9 | 1.0 ± 5.3 | 0.1 | 0.57 |
| Age-Predicted HRmax (%) | 10 | 87.9 ± 5.9 | 88.5 ± 8.0 | 0.6 ± 2.7 | 0.1 | 0.51 |
| RPE | 9 | 18.9 ± 1.3 | 17.7 ± 1.3 | −1.4 ± 2.0 | 0.9 | 0.06 |
| HRR @ 5-min (bpm) | 8 | 121.3 ± 13.9 | 119.5 ± 12.7 | −2.9 ± 6.7 | 0.1 | 0.26 |
HRmax = maximum heart rate; MWR = maximal work rate; RER = respiratory exchange ratio; RPE = ratings of perceived exertion; VE = ventilation; V̇CO2peak = peak carbon dioxide expiration; V̇O2peak = peak oxygen consumption; * significant alpha level at p < 0.05.